SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-15-000330
Filing Date
2015-03-04
Accepted
2015-03-04 16:10:18
Documents
2
Period of Report
2015-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CORCEPT THERAPEUTICS 8-K corcept8k.htm 8-K 5074
2 PRESS RELEASE corcepttherapeutics.htm EX-99 18739
  Complete submission text file 0001102624-15-000330.txt   24956
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 15673489
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1